此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Sleep and Performance (MTEC Phase 2)

2026年5月19日 更新者:Jeffrey John Iliff、University of Washington

Augmented Neurophysiology of Sleep and Performance Readiness

This research is being done to apply new, contrast-free MRI (Magnetic Resonance Imaging) methods to understand the brain's waste clearance system (the "glymphatic" system) in younger adults. The Investigators hope the study will show how the different brain regions are involved in maintaining memories and how poor sleep affects these regions and our ability to remember. The Investigators will test whether the Wireless Interface Sensor Pod (WISP) improves brain function after poor sleep. The WISP is a headband that combines tracking brain waves and transcranial electrical stimulation (TES) to monitor and improve slow wave sleep and glymphatic clearance.

IParticipants will be asked to:

  • Complete 4 in-person study visits (1 per week) over 4 weeks at the Diagnostic Imaging Sciences Center (DISC), located at the University of Washington Medical Center at Montlake, Seattle. Each visit will last 2 hours and includes a 1 hour MRI and 1 hour of cognitive testing.
  • Complete a daily journal about sleep, daily habits, etc.
  • The night before each of the four study visits, participants will sleep while wearing the WISP headband.

    • For two of these nights, participants will sleep only 3 hours prior to normal time of awakening. The WISP will deliver a small electrical current for one night and not for the other night, but participants will not know which.
    • For the other two nights, participants will follow a normal sleep schedule. The WISP will deliver a small electrical current for one night and not for the other night, but participants will not know which.

研究概览

详细说明

Sleep is a fundamental element of brain health and function, supporting the processes of learning and memory consolidation, maintenance and repair, and waste clearance. Acute sleep deprivation, a frequent operational necessity among warfighters, significantly impairs attention, vigilance, processing speed, executive function, motor coordination and memory. Chronic sleep restriction, a condition common among service members during combat deployments and operations, erodes cognitive and physical performance and is a major limitation on sustained operational readiness.

The newly-discovered glymphatic system supports the rapid exchange of fluid through brain tissue during sleep, facilitating the clearance of wastes that accumulate through the course of waking activity. Increased glymphatic clearance occurs in the deepest (slow wave, N3) stage of sleep and is facilitated by the dynamic enlargement of the brain's extracellular space during slow wave activity. Sleep-active glymphatic function is postulated to underlie the restorative function of sleep on cognition, and its impairment is proposed to drive the cognitive impacts of sleep disruption. This suggests that improving glymphatic function, whether pharmacologically or by means of a device, could ameliorate the cognitive effects of acute sleep deprivation and chronic sleep restriction.

The proposed technology, Augmented Neural Oscillation Driver or 'AugNOD', is an easily-applied, wireless, combined electroencephalography (EEG)/transcranial electrical stimulation (TES) headband that can be applied before sleep to monitor and improve slow wave sleep and glymphatic clearance. The AugNOD system utilizes two complimentary protocols to support glymphatic function: 1) the integrated TES Slow Oscillation (TES SO) promotes slow wave sleep, engaging sleep-active glymphatic clearance; 2) the Direct Current Glymphatic Clearance (DCGC) protocol directly improves glymphatic function through enhancement of brain extracellular diffusion. BEL has obtained an FDA presubmission query for the Neurosom EEG Assessment Technology (NEAT) for automated sleep staging using machine learning (Convolutional Neural Nets) with validation from AASM-Certified commercial scoring. This should complete soon, and the Investigators expect FDA clearance for NEAT by early 2022. In addition, BEL has obtained an FDA review for TES synchronization of SOs with the Intended Use of improving deep sleep (N3) in healthy adults.

Although the presence of sleep-active glymphatic exchange has only recently been confirmed in human subjects, no pharmacological or device-based approach has yet demonstrated that glymphatic function can be modulated in the human brain. In Objective 1, the investigators will test whether enhancing slow wave sleep using the AugNOD TES SO protocol improves overnight glymphatic function measured by MRI. By comparing effects between subject undergoing total sleep deprivation, restricted natural sleep, and restricted natural sleep with TES slow wave synchronization, this study will determine whether extending slow wave sleep with TES leads to improvement of glymphatic clearance and regional molecular diffusion by multimodal MRI, The Investigators will also perform Magnetic Resonance Elastography (MRE) on the healthy human brain in multiple directions to calculate directional stiffness of the brain tissue. An MRE actuator vibrational device (pillow) will be used to apply vibration to the subject's head in one direction and then another, and then to use this information to calculate the stiffness of brain tissue. The investigators will combine the information from the MRE scan and the information from the other MRI scans performed to simulate brain motion and calculate accurate mechanical properties of the brain.

Although glymphatic function has been proposed to underlie the restorative effects of sleep on cognitive function, and its impairment has been thought to contribute to cognitive deficits resulting from sleep deprivation, this connection has never been directly tested experimentally in animal models or in human subjects. In Objective 2, the research will test whether AugNOD TES SO improves sleep restriction-associated cognitive impairment. Sleep restriction will be coupled with a demanding vigilance task to simulate the challenges of performance under operational conditions. Since slow wave sleep likely exerts a restorative effect on cognitive function independent of glymphatic clearance, the TES SO protocol may also improve subsequent cognitive performance through enhancement of sleep efficiency.

研究类型

介入性

注册 (估计的)

16

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Yeilim Cho, MD
  • 电话号码:(206) 277-7207
  • 邮箱:ycho7@uw.edu

研究联系人备份

学习地点

    • Washington
      • Seattle、Washington、美国、98125
        • 招聘中
        • University of Washington School of Medicine
        • 接触:
          • Yeilim Cho, MD
          • 电话号码:(206) 277-7207
          • 邮箱:ycho7@uw.edu

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

是的

描述

Inclusion Criteria:

  1. Physically and psychologically healthy
  2. Good habitual sleep between 6 and 10 hours in duration, as assessed by questionnaire and pre-study week sleep/wake diary
  3. Regular bedtimes, habitually getting up between 05:00 and 09:00, as assessed by questionnaire and pre-study week sleep/wake diary

Exclusion Criteria:

  • Subjects who have any type of non-MRI compatible bioimplant activated by mechanical, electronic, or magnetic means (e.g., cochlear implants, pacemakers, neurostimulators, biostimulators, electronic infusion pumps, etc.), because such devices may be displaced or malfunction.
  • Subjects who have any type of ferromagnetic bioimplant that could potentially be displaced.
  • Subjects who have cerebral aneurysm
  • Subjects who may have shrapnel imbedded in their bodies (such as from war wounds), metal workers and machinists (potential for metallic fragments in or near the eyes).
  • Minors (younger than 18 years)
  • Pregnant women ( Participants of childbearing potential will receive a urine pregnancy test. If the test is positive, the participant will be excluded)
  • Breastfeeding
  • Subjects who cannot adhere to the experimental protocols for any reason, or have an inability to communicate with the researcher.
  • no clinical disorders and/or illnesses, no psychiatric illnesses), as assessed by history and questionnaires
  • no alcohol during study and no normal excessive alcohol consumption assessed by questionnaire
  • No history of drug or alcohol abuse in the past year and no history of methamphetamine abuse, as assessed by questionnaires.
  • Not a dependent smoker or vaper, and not morning dependent on tobacco, nicotine, or cannabis, as assessed by questionnaire.
  • No history of moderate to severe brain injury, as assessed by questionnaire
  • No anti-psychotic medication for ADHD/ADD, as assessed by questionnaire
  • No previous adverse reaction to sleep deprivation, as assessed by questionnaire
  • Not vision-impaired unless corrected back to normal.
  • Not hearing impaired unless corrected to normal, as assessed by questionnaire
  • Not pregnant, as assessed by history and questionnaire
  • No sleep or circadian disorder, as assessed by questionnaires
  • No use of melatonin within 1 week of study enrollment
  • No travel across more than one time zone within one month of entering the study and no crossing times zones during study participation, as assessed by questionnaire.
  • No shift work within three months of entering the study and no shift work during duration study participation, as assessed by questionnaire.
  • epilepsy

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
假比较器:Sleep restriction, no TES
Participants will have sleep restriction, sham TES
Participants will wear the WISP device, but no TES
实验性的:Sleep restriction, TES
Participants will have sleep restriction, will have active TES
Participants will wear the Wireless Interface Sensor Pod (WISP), which combines EEG with Transcranial Electrical Stimulation (TES)
假比较器:Normal sleep, no TES
Participants will follow normal sleep schedule, sham TES
Participants will wear the WISP device, but no TES
实验性的:Normal sleep, TES
Participants will follow normal sleep schedule, will have TES
Participants will wear the Wireless Interface Sensor Pod (WISP), which combines EEG with Transcranial Electrical Stimulation (TES)

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Multimodal MRI
大体时间:Immediately after the intervention with sleep condition and TES
We will test whether enhancing slow-wave sleep using the AugNOD TES SO improves overnight glymphatic function, as measured by non-invasive multimodal MRI-based markers of glymphatic activity: (i) diffusion-based intravoxel incoherent motion (IVIM)-MRI assessing long-distance water transport (diffusion signal); (ii) fast functional MRI (f-MRI) measuring low-frequency vasomotor oscillations; (iii) T1/FLAIR-based assessment of MRI-visible perivascular spaces (MV-PVS), which serve as structural indicators of perivascular impairment; (iv) multi-echo arterial spin-labeling (ME-ASL)-MRI assessing glial-vascular water transport ; and (v) Magnetic Resonance Elastography (MRE) measuring brain tissue stiffness.
Immediately after the intervention with sleep condition and TES

次要结果测量

结果测量
措施说明
大体时间
Psychomotor Vigilance Task (PVT)
大体时间:Immediately after the intervention with sleep condition and TES
The PVT is a test of sustained attention, measuring the speed at which individuals respond to visual stimuli. The test requires participants to rapidly respond to visual cues presented within specified interstimulus intervals. Participants are asked to press a button as soon as they see a light appear on a screen, with the light turning on at random intervals, Response times are recorded and evaluated.
Immediately after the intervention with sleep condition and TES
Go/no go task
大体时间:Immediately after the intervention with sleep condition and TES
A decision-making task that requires a participant to respond or withhold a response based on feedback from the computer using arrows or numbers as cues. Number of errors are recorded.
Immediately after the intervention with sleep condition and TES
The Digit Symbol Substitution Test (DSST)
大体时间:Immediately after the intervention with sleep condition and TES
A brief timed coding task (typically 90-120 seconds) in which people use a key to pair digits with symbols and produce as many correct matches as possible. Number of errors will be recorded
Immediately after the intervention with sleep condition and TES
Digit Span
大体时间:Immediately after the intervention with sleep condition and TES
Participants are asked to recall sequences of numbers in order. The longest sequence will be measured.
Immediately after the intervention with sleep condition and TES
Positive and Negative Affect Schedule (PANAS)
大体时间:Immediately after the intervention with sleep condition and TES
20-item self- report measure to assess positive affect (PA) and negative affect (NA) on a 5-point Likert scale. Total positive and total negative affect scores will be recorded.
Immediately after the intervention with sleep condition and TES

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Jeffrey Iliff, PhD、University of Washington

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年10月1日

初级完成 (估计的)

2027年6月1日

研究完成 (估计的)

2027年6月1日

研究注册日期

首次提交

2026年5月12日

首先提交符合 QC 标准的

2026年5月19日

首次发布 (实际的)

2026年5月27日

研究记录更新

最后更新发布 (实际的)

2026年5月27日

上次提交的符合 QC 标准的更新

2026年5月19日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

其他研究编号

  • STUDY00021849
  • W81XWH-21-09-0021-129 (其他赠款/资助编号:Department of Defense)

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅